New clinical trial
Transcranial Random Noise (tRNS) for Behavioral and Psychological Symptoms in Alzheimer's Disease (BPSD): A Randomized, Double-blind, Sham-Controlled Trial
@gregoryai.bsky.social
@gregoryai.bsky.socialNew clinical trial
Transcranial Random Noise (tRNS) for Behavioral and Psychological Symptoms in Alzheimer's Disease (BPSD): A Randomized, Double-blind, Sham-Controlled Trial
@gregoryai.bsky.socialNew clinical trial
Phase 1B Trial on Escalating Doses of Memantine in Down Syndrome
@gregoryai.bsky.socialNew clinical trial
Efficacy and Safety of Photobiomodulation Therapy in Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease, A 6-Month, Single-Center, Randomized, Double-Blind, Controlled Trial
@gregoryai.bsky.socialNew clinical trial
Brain Heath Service for Prevention of AD
@gregoryai.bsky.socialNew clinical trial
Cognition and Affective Research in China
@gregoryai.bsky.socialNew clinical trial
A Phase 2a, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of NBI-1117567 in Participants With Mild to Moderate Alzheimer's Disease on Stable Treatment With an Acetylcho...
@gregoryai.bsky.socialNew clinical trial
Mechanisms of Action, Efficacy, and Feasibility of a Web-Based Cognitive Behavioral Therapy for Insomnia Intervention in Spousal Alzheimer's Disease and Related Dementias Caregivers
@gregoryai.bsky.socialNew clinical trial
Improving Mental Health and Social Connectivity for Older Adults Through Virtual Reality-Based Social Interventions
@gregoryai.bsky.socialNew clinical trial
A Phase 4, Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety and Tolerability of Donanemab in Indian Participants With Early Symptomatic Alzheimer's Disease
@gregoryai.bsky.socialNew clinical trial
Evaluating the Health Benefits of Jigsawdio: A Novel Multisensory Jigsaw Puzzle-Based Platform for Alzheimer's Disease and Related Dementias
@gregoryai.bsky.socialNew clinical trial
Interventional Study to Evaluate the Effectiveness of Transcranial Alternating Current Stimulation (tACS) Combined With Cognitive Training on Cognitive Performance in Patients With Alzheimer's Disease
@gregoryai.bsky.socialNew clinical trial
A Phase II Clinical Trial on the Effect of a Mitophagy Inducer Urolithin A on Alzheimer's Disease
@gregoryai.bsky.socialNew clinical trial
Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System) in Mild to Moderate AD Patients
@embomolmed.orgThe beautiful cover of our September issue highlights the article by H. Wong, H. Chen, N. Ip & colleagues: “#DeepPlaque: a scalable multimodal platform for Aβ pathology and cell analysis in #AlzheimersDisease” 👉 doi.org/10.1038/s44321-026-00488-4
Scientific illustration by the authors
@molneurodegenadvnc.bsky.socialConformation-specific anti-pathological tau #antibody raised against AD brain-derived seed-competent tau reduces tau pathology in transgenic mice
Kiran Yanamandra, Nandini Romanul, Hiral Patel...Xavier Langlois #AlzheimersDisease #immunotherapy
@tenuretracker.bsky.socialHelmholtz Information & Data Science Academy (HiDA) is hiring:
Postdoctoral Researcher in Remote and Unsupervised Smartphone-Based Assessments in Early Alzheimer's Disease
@molneurodegenadvnc.bsky.socialEpitope placement tunes CSF tau #biomarkers: Comparison of P- #tau217 and BD-tau designs
Helena Sophia Gleerup, Christian Sandøe Musaeus...Anja Hviid Simonsen & Fernando Gonzalez Ortiz #AlzheimersDisease
@molneurodegen.bsky.social#Astrocyte reactivity identifies p- #tau217 -positive individuals at elevated risk of cognitive decline across the #AlzheimersDisease continuum
Bruna Bellaver, Guilherme Povala, Pamela C. L. Ferreira...Tharick A. Pascoal @pittdeptofmed.bsky.social
@genseq.bsky.socialThis article reviews the genetic factors associated with Alzheimer’s disease: lnkd.in/p/dwHqz-jU
Informed by Consultant Geneticists with extensive clinical experience, helping to ensure it is accurate, relevant and clinically useful.
#AlzheimersDisease #Alzheimers #WorldAlzheimersDay #Genetics
@topladave.bsky.social"With all the advances in both the science of aging and [#AI], we are in a propitious position to accurately and precisely determine who is at high risk of developing #AlzheimersDisease years before signs of even mild cognitive deficit," writes Eric Topol in a Science Expert Voices article.